$ALBO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALBIREO PHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ALBIREO PHARMA, INC.. Get notifications about new insider transactions in ALBIREO PHARMA, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 26 2021 | ALBO | ALBIREO PHARMA, IN ... | Duncan Jason | Chief Legal Officer ... | Sell | S | 32.32 | 222 | 7,175 | 7,849 | 8.1 K to 7.8 K (-2.75 %) |
Apr 26 2021 | ALBO | ALBIREO PHARMA, IN ... | Duncan Jason | Chief Legal Officer ... | Sell | S | 31.75 | 90 | 2,858 | 8,071 | 8.2 K to 8.1 K (-1.10 %) |
Apr 26 2021 | ALBO | ALBIREO PHARMA, IN ... | Horn Patrick Taylor | Chief Medical Offic ... | Sell | S | 31.75 | 90 | 2,858 | 11,893 | 12 K to 11.9 K (-0.75 %) |
Apr 14 2021 | ALBO | ALBIREO PHARMA, IN ... | Harford Simon N.R. | CFO and Treasurer | Sell | S | 32.12 | 92 | 2,955 | 12,196 | 12.3 K to 12.2 K (-0.75 %) |
Apr 02 2021 | ALBO | ALBIREO PHARMA, IN ... | Duncan Jason | Chief Legal Officer ... | Option Exercise | M | 24.04 | 300 | 7,212 | 19,200 | |
Apr 02 2021 | ALBO | ALBIREO PHARMA, IN ... | Duncan Jason | Chief Legal Officer ... | Sell | S | 36.16 | 300 | 10,847 | 8,161 | 8.5 K to 8.2 K (-3.55 %) |
Apr 02 2021 | ALBO | ALBIREO PHARMA, IN ... | Duncan Jason | Chief Legal Officer ... | Buy | M | 24.04 | 300 | 7,212 | 8,461 | 8.2 K to 8.5 K (+3.68 %) |
Apr 02 2021 | ALBO | ALBIREO PHARMA, IN ... | Duncan Jason | Chief Legal Officer ... | Sell | S | 35.04 | 1,426 | 49,969 | 8,161 | 9.6 K to 8.2 K (-14.87 %) |
Mar 31 2021 | ALBO | ALBIREO PHARMA, IN ... | Stephenson Pamela | Chief Commercial Of ... | Sell | S | 34.02 | 422 | 14,355 | 26,985 | 27.4 K to 27 K (-1.54 %) |
Jan 25 2021 | ALBO | ALBIREO PHARMA, IN ... | Harford Simon N.R. | CFO and Treasurer | Option Exercise | A | 34.88 | 23,700 | 826,656 | 23,700 | |
Jan 25 2021 | ALBO | ALBIREO PHARMA, IN ... | Harford Simon N.R. | CFO and Treasurer | Grant | A | 0.00 | 5,500 | 0 | 10,114 | 4.6 K to 10.1 K (+119.20 %) |
Jan 25 2021 | ALBO | ALBIREO PHARMA, IN ... | Duncan Jason | Chief Legal Officer ... | Option Exercise | A | 34.88 | 23,700 | 826,656 | 23,700 | |
Jan 25 2021 | ALBO | ALBIREO PHARMA, IN ... | Duncan Jason | Chief Legal Officer ... | Sell | S | 34.62 | 110 | 3,808 | 9,332 | 9.4 K to 9.3 K (-1.17 %) |
Jan 25 2021 | ALBO | ALBIREO PHARMA, IN ... | Duncan Jason | Chief Legal Officer ... | Grant | A | 0.00 | 5,500 | 0 | 9,442 | 3.9 K to 9.4 K (+139.52 %) |
Jan 25 2021 | ALBO | ALBIREO PHARMA, IN ... | Mattsson Jan | Chief Scientific Of ... | Option Exercise | A | 34.88 | 23,700 | 826,656 | 23,700 | |
Jan 25 2021 | ALBO | ALBIREO PHARMA, IN ... | Mattsson Jan | Chief Scientific Of ... | Grant | A | 0.00 | 5,500 | 0 | 29,714 | 24.2 K to 29.7 K (+22.71 %) |
Jan 25 2021 | ALBO | ALBIREO PHARMA, IN ... | Carter Martha J. | Chief Regulatory Of ... | Option Exercise | A | 34.88 | 23,700 | 826,656 | 23,700 | |
Jan 25 2021 | ALBO | ALBIREO PHARMA, IN ... | Carter Martha J. | Chief Regulatory Of ... | Grant | A | 0.00 | 5,500 | 0 | 5,500 | 0 to 5.5 K |
Jan 25 2021 | ALBO | ALBIREO PHARMA, IN ... | Graham Michelle | Chief Human Resourc ... | Option Exercise | A | 34.88 | 23,700 | 826,656 | 23,700 | |
Jan 25 2021 | ALBO | ALBIREO PHARMA, IN ... | Graham Michelle | Chief Human Resourc ... | Grant | A | 0.00 | 5,500 | 0 | 5,500 | 0 to 5.5 K |
Jan 25 2021 | ALBO | ALBIREO PHARMA, IN ... | Horn Patrick Taylor | Chief Medical Offic ... | Option Exercise | A | 34.88 | 23,700 | 826,656 | 23,700 | |
Jan 25 2021 | ALBO | ALBIREO PHARMA, IN ... | Horn Patrick Taylor | Chief Medical Offic ... | Sell | S | 34.62 | 110 | 3,808 | 9,825 | 9.9 K to 9.8 K (-1.11 %) |
Jan 25 2021 | ALBO | ALBIREO PHARMA, IN ... | Horn Patrick Taylor | Chief Medical Offic ... | Grant | A | 0.00 | 5,500 | 0 | 9,935 | 4.4 K to 9.9 K (+124.01 %) |
Jan 25 2021 | ALBO | ALBIREO PHARMA, IN ... | Stephenson Pamela | Chief Commercial Of ... | Option Exercise | A | 34.88 | 23,700 | 826,656 | 23,700 | |
Jan 25 2021 | ALBO | ALBIREO PHARMA, IN ... | Stephenson Pamela | Chief Commercial Of ... | Grant | A | 0.00 | 5,500 | 0 | 27,407 | 21.9 K to 27.4 K (+25.11 %) |
Jan 25 2021 | ALBO | ALBIREO PHARMA, IN ... | Cooper Ronald Harold Wilfred | President and CEO | Option Exercise | A | 34.88 | 93,000 | 3,243,840 | 93,000 | |
Jan 25 2021 | ALBO | ALBIREO PHARMA, IN ... | Cooper Ronald Harold Wilfred | President and CEO | Grant | A | 0.00 | 48,700 | 0 | 56,460 | 7.8 K to 56.5 K (+627.58 %) |
Jan 13 2021 | ALBO | ALBIREO PHARMA, IN ... | Harford Simon N.R. | CFO and Treasurer | Sell | S | 37.33 | 110 | 4,107 | 4,614 | 4.7 K to 4.6 K (-2.33 %) |
Dec 29 2020 | ALBO | ALBIREO PHARMA, IN ... | Stephenson Pamela | Chief Commercial Of ... | Sell | S | 39.07 | 460 | 17,974 | 21,907 | 22.4 K to 21.9 K (-2.06 %) |
Oct 23 2020 | ALBO | ALBIREO PHARMA, IN ... | Horn Patrick Taylor | Chief Medical Offic ... | Sell | S | 34.55 | 89 | 3,075 | 4,285 | 4.4 K to 4.3 K (-2.03 %) |
Oct 23 2020 | ALBO | ALBIREO PHARMA, IN ... | Duncan Jason | Chief Legal Officer ... | Sell | S | 34.71 | 89 | 3,089 | 3,781 | 3.9 K to 3.8 K (-2.30 %) |
Oct 13 2020 | ALBO | ALBIREO PHARMA, IN ... | Harford Simon N.R. | CFO and Treasurer | Sell | S | 37.30 | 90 | 3,357 | 4,616 | 4.7 K to 4.6 K (-1.91 %) |
Sep 25 2020 | ALBO | ALBIREO PHARMA, IN ... | Stephenson Pamela | Chief Commercial Of ... | Sell | S | 33.20 | 451 | 14,973 | 22,367 | 22.8 K to 22.4 K (-1.98 %) |
Sep 15 2020 | ALBO | ALBIREO PHARMA, IN ... | Carter Martha J. | Chief Regulatory Of ... | Option Exercise | M | 29.76 | 938 | 27,915 | 62,009 | |
Sep 15 2020 | ALBO | ALBIREO PHARMA, IN ... | Carter Martha J. | Chief Regulatory Of ... | Option Exercise | M | 24.48 | 9,062 | 221,838 | 3,250 | |
Sep 15 2020 | ALBO | ALBIREO PHARMA, IN ... | Carter Martha J. | Chief Regulatory Of ... | Sell | S | 40.03 | 10,000 | 400,300 | 0 | 10 K to 0 (-100.00 %) |
Sep 15 2020 | ALBO | ALBIREO PHARMA, IN ... | Carter Martha J. | Chief Regulatory Of ... | Buy | M | 29.76 | 938 | 27,915 | 10,000 | 9.1 K to 10 K (+10.35 %) |
Sep 15 2020 | ALBO | ALBIREO PHARMA, IN ... | Carter Martha J. | Chief Regulatory Of ... | Buy | M | 24.48 | 9,062 | 221,838 | 9,062 | 0 to 9.1 K |
Sep 15 2020 | ALBO | ALBIREO PHARMA, IN ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 40.00 | 400,000 | 16,000,000 | 2,360,139 | 2 M to 2.4 M (+20.41 %) |
Sep 10 2020 | ALBO | ALBIREO PHARMA, IN ... | Carter Martha J. | Chief Regulatory Of ... | Option Exercise | M | 24.48 | 688 | 16,842 | 12,312 | |
Sep 10 2020 | ALBO | ALBIREO PHARMA, IN ... | Carter Martha J. | Chief Regulatory Of ... | Option Exercise | M | 24.04 | 9,312 | 223,860 | 19,688 | |
Sep 10 2020 | ALBO | ALBIREO PHARMA, IN ... | Carter Martha J. | Chief Regulatory Of ... | Option Exercise | M | 24.04 | 2,500 | 60,100 | 29,000 | |
Sep 10 2020 | ALBO | ALBIREO PHARMA, IN ... | Carter Martha J. | Chief Regulatory Of ... | Option Exercise | M | 19.19 | 7,500 | 143,925 | 2,500 | |
Sep 10 2020 | ALBO | ALBIREO PHARMA, IN ... | Carter Martha J. | Chief Regulatory Of ... | Option Exercise | M | 19.19 | 10,000 | 191,900 | 10,000 | |
Sep 10 2020 | ALBO | ALBIREO PHARMA, IN ... | Carter Martha J. | Chief Regulatory Of ... | Sell | S | 42.41 | 10,000 | 424,100 | 0 | 10 K to 0 (-100.00 %) |
Sep 10 2020 | ALBO | ALBIREO PHARMA, IN ... | Carter Martha J. | Chief Regulatory Of ... | Buy | M | 24.48 | 688 | 16,842 | 10,000 | 9.3 K to 10 K (+7.39 %) |
Sep 10 2020 | ALBO | ALBIREO PHARMA, IN ... | Carter Martha J. | Chief Regulatory Of ... | Buy | M | 24.04 | 9,312 | 223,860 | 9,312 | 0 to 9.3 K |
Sep 10 2020 | ALBO | ALBIREO PHARMA, IN ... | Carter Martha J. | Chief Regulatory Of ... | Sell | S | 39.82 | 2,500 | 99,550 | 0 | 2.5 K to 0 (-100.00 %) |
Sep 10 2020 | ALBO | ALBIREO PHARMA, IN ... | Carter Martha J. | Chief Regulatory Of ... | Sell | S | 38.68 | 7,500 | 290,100 | 2,500 | 10 K to 2.5 K (-75.00 %) |
Sep 10 2020 | ALBO | ALBIREO PHARMA, IN ... | Carter Martha J. | Chief Regulatory Of ... | Buy | M | 24.04 | 2,500 | 60,100 | 10,000 | 7.5 K to 10 K (+33.33 %) |
Sep 10 2020 | ALBO | ALBIREO PHARMA, IN ... | Carter Martha J. | Chief Regulatory Of ... | Buy | M | 19.19 | 7,500 | 143,925 | 7,500 | 0 to 7.5 K |
Sep 10 2020 | ALBO | ALBIREO PHARMA, IN ... | Carter Martha J. | Chief Regulatory Of ... | Sell | S | 45.55 | 10,000 | 455,500 | 0 | 10 K to 0 (-100.00 %) |
Sep 10 2020 | ALBO | ALBIREO PHARMA, IN ... | Carter Martha J. | Chief Regulatory Of ... | Buy | M | 19.19 | 10,000 | 191,900 | 10,000 | 0 to 10 K |
Sep 10 2020 | ALBO | ALBIREO PHARMA, IN ... | Duncan Jason | Chief Legal Officer ... | Option Exercise | M | 24.04 | 3,500 | 84,140 | 19,500 | |
Sep 10 2020 | ALBO | ALBIREO PHARMA, IN ... | Duncan Jason | Chief Legal Officer ... | Sell | S | 45.55 | 4,000 | 182,200 | 3,870 | 7.9 K to 3.9 K (-50.83 %) |
Sep 10 2020 | ALBO | ALBIREO PHARMA, IN ... | Duncan Jason | Chief Legal Officer ... | Buy | M | 24.04 | 3,500 | 84,140 | 7,870 | 4.4 K to 7.9 K (+80.09 %) |
Sep 10 2020 | ALBO | ALBIREO PHARMA, IN ... | Mattsson Jan | Chief Scientific Of ... | Sell | S | 45.55 | 10,000 | 455,500 | 24,214 | 34.2 K to 24.2 K (-29.23 %) |
Jul 23 2020 | ALBO | ALBIREO PHARMA, IN ... | Duncan Jason | Chief Legal Officer ... | Sell | S | 25.80 | 91 | 2,348 | 4,370 | 4.5 K to 4.4 K (-2.04 %) |
Jul 23 2020 | ALBO | ALBIREO PHARMA, IN ... | Horn Patrick Taylor | Chief Medical Offic ... | Sell | S | 25.80 | 91 | 2,348 | 4,374 | 4.5 K to 4.4 K (-2.04 %) |
Jul 10 2020 | ALBO | ALBIREO PHARMA, IN ... | Harford Simon N.R. | CFO and Treasurer | Sell | S | 25.56 | 92 | 2,352 | 4,706 | 4.8 K to 4.7 K (-1.92 %) |
Jun 26 2020 | ALBO | ALBIREO PHARMA, IN ... | Stephenson Pamela | Chief Commercial Of ... | Sell | S | 30.79 | 397 | 12,224 | 22,818 | 23.2 K to 22.8 K (-1.71 %) |
Jun 19 2020 | ALBO | ALBIREO PHARMA, IN ... | Chiswell David | Director | Option Exercise | A | 27.89 | 8,000 | 223,120 | 8,000 | |
Jun 19 2020 | ALBO | ALBIREO PHARMA, IN ... | SCOON DAVEY | Director | Option Exercise | A | 27.89 | 8,000 | 223,120 | 8,000 | |
Jun 19 2020 | ALBO | ALBIREO PHARMA, IN ... | Okey Stephanie | Director | Option Exercise | A | 27.89 | 8,000 | 223,120 | 8,000 | |
Jun 19 2020 | ALBO | ALBIREO PHARMA, IN ... | Klibanski Anne | Director | Option Exercise | A | 27.89 | 8,000 | 223,120 | 8,000 | |
Jun 19 2020 | ALBO | ALBIREO PHARMA, IN ... | JEFFS ROGER | Director | Option Exercise | A | 27.89 | 8,000 | 223,120 | 8,000 | |
Jun 19 2020 | ALBO | ALBIREO PHARMA, IN ... | Gutch Michael | Director | Option Exercise | A | 27.89 | 8,000 | 223,120 | 8,000 | |
Apr 24 2020 | ALBO | ALBIREO PHARMA, IN ... | Horn Patrick Taylor | Chief Medical Offic ... | Sell | S | 17.64 | 92 | 1,623 | 4,465 | 4.6 K to 4.5 K (-2.02 %) |
Apr 24 2020 | ALBO | ALBIREO PHARMA, IN ... | Duncan Jason | Chief Legal Officer ... | Sell | S | 17.68 | 92 | 1,627 | 4,461 | 4.6 K to 4.5 K (-2.02 %) |
Apr 13 2020 | ALBO | ALBIREO PHARMA, IN ... | Harford Simon N.R. | CFO and Treasurer | Sell | S | 16.52 | 97 | 1,602 | 4,798 | 4.9 K to 4.8 K (-1.98 %) |
Mar 25 2020 | ALBO | ALBIREO PHARMA, IN ... | Stephenson Pamela | Chief Commercial Of ... | Sell | S | 17.60 | 1,785 | 31,416 | 23,215 | 25 K to 23.2 K (-7.14 %) |
Feb 04 2020 | ALBO | ALBIREO PHARMA, IN ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 21.00 | 255,809 | 5,371,989 | 1,960,139 | 1.7 M to 2 M (+15.01 %) |
Jan 23 2020 | ALBO | ALBIREO PHARMA, IN ... | Mattsson Jan | Chief Operating Off ... | Option Exercise | A | 24.67 | 31,500 | 777,105 | 31,500 | |
Jan 23 2020 | ALBO | ALBIREO PHARMA, IN ... | Horn Patrick Taylor | Chief Medical Offic ... | Option Exercise | A | 24.67 | 31,500 | 777,105 | 31,500 | |
Jan 23 2020 | ALBO | ALBIREO PHARMA, IN ... | Horn Patrick Taylor | Chief Medical Offic ... | Sell | S | 24.29 | 443 | 10,760 | 4,557 | 5 K to 4.6 K (-8.86 %) |
Jan 23 2020 | ALBO | ALBIREO PHARMA, IN ... | Duncan Jason | Chief Legal Officer ... | Option Exercise | A | 24.67 | 31,500 | 777,105 | 31,500 | |
Jan 23 2020 | ALBO | ALBIREO PHARMA, IN ... | Duncan Jason | Chief Legal Officer ... | Sell | S | 23.97 | 447 | 10,715 | 4,553 | 5 K to 4.6 K (-8.94 %) |
Jan 23 2020 | ALBO | ALBIREO PHARMA, IN ... | Graham Michelle | Chief Human Resourc ... | Option Exercise | A | 24.67 | 31,500 | 777,105 | 31,500 | |
Jan 23 2020 | ALBO | ALBIREO PHARMA, IN ... | Carter Martha J. | Chief Regulatory Of ... | Option Exercise | A | 24.67 | 31,500 | 777,105 | 31,500 | |
Jan 23 2020 | ALBO | ALBIREO PHARMA, IN ... | Harford Simon N.R. | CFO and Treasurer | Option Exercise | A | 24.67 | 31,500 | 777,105 | 31,500 | |
Jan 23 2020 | ALBO | ALBIREO PHARMA, IN ... | Cooper Ronald Harold Wilfred | President and CEO | Option Exercise | A | 24.67 | 124,000 | 3,059,080 | 124,000 | |
Jan 23 2020 | ALBO | ALBIREO PHARMA, IN ... | Stephenson Pamela | Chief Commercial Of ... | Option Exercise | A | 24.67 | 31,500 | 777,105 | 31,500 | |
Jan 14 2020 | ALBO | ALBIREO PHARMA, IN ... | Harford Simon N.R. | CFO and Treasurer | Sell | S | 27.20 | 105 | 2,856 | 4,895 | 5 K to 4.9 K (-2.10 %) |
Nov 04 2019 | ALBO | ALBIREO PHARMA, IN ... | Graham Michelle | Chief Human Resourc ... | Option Exercise | A | 19.32 | 37,500 | 724,500 | 37,500 | |
Nov 04 2019 | ALBO | ALBIREO PHARMA, IN ... | Graham Michelle | Chief Human Resourc ... | Option Exercise | A | 19.32 | 37,500 | 724,500 | 37,500 | |
Jun 25 2019 | ALBO | ALBIREO PHARMA, IN ... | SCOON DAVEY | Director | Option Exercise | A | 31.22 | 5,500 | 171,710 | 5,500 | |
Jun 25 2019 | ALBO | ALBIREO PHARMA, IN ... | Chiswell David | Director | Option Exercise | A | 31.22 | 5,500 | 171,710 | 5,500 | |
Jun 25 2019 | ALBO | ALBIREO PHARMA, IN ... | Okey Stephanie | Director | Option Exercise | A | 31.22 | 5,500 | 171,710 | 5,500 | |
Jun 25 2019 | ALBO | ALBIREO PHARMA, IN ... | Klibanski Anne | Director | Option Exercise | A | 31.22 | 5,500 | 171,710 | 5,500 | |
Jun 25 2019 | ALBO | ALBIREO PHARMA, IN ... | Klibanski Anne | Director | Option Exercise | A | 31.22 | 5,500 | 171,710 | 5,500 | |
Jun 25 2019 | ALBO | ALBIREO PHARMA, IN ... | JEFFS ROGER | Director | Option Exercise | A | 31.22 | 5,500 | 171,710 | 5,500 | |
Jun 25 2019 | ALBO | ALBIREO PHARMA, IN ... | JEFFS ROGER | Director | Option Exercise | A | 31.22 | 5,500 | 171,710 | 5,500 | |
Jun 25 2019 | ALBO | ALBIREO PHARMA, IN ... | Gutch Michael | Director | Option Exercise | A | 31.22 | 5,500 | 171,710 | 5,500 | |
Jun 25 2019 | ALBO | ALBIREO PHARMA, IN ... | Gutch Michael | Director | Option Exercise | A | 31.22 | 5,500 | 171,710 | 5,500 | |
Mar 27 2019 | ALBO | ALBIREO PHARMA, IN ... | Stephenson Pamela | Chief Commercial Of ... | Option Exercise | A | 28.76 | 37,500 | 1,078,500 | 37,500 | |
Mar 27 2019 | ALBO | ALBIREO PHARMA, IN ... | Stephenson Pamela | Chief Commercial Of ... | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
Jan 24 2019 | ALBO | ALBIREO PHARMA, IN ... | Horn Patrick Taylor | Chief Medical Offic ... | Option Exercise | A | 24.04 | 23,000 | 552,920 | 23,000 | |
Jan 24 2019 | ALBO | ALBIREO PHARMA, IN ... | Horn Patrick Taylor | Chief Medical Offic ... | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
Jan 24 2019 | ALBO | ALBIREO PHARMA, IN ... | Duncan Jason | General Counsel | Option Exercise | A | 24.04 | 23,000 | 552,920 | 23,000 | |
Jan 24 2019 | ALBO | ALBIREO PHARMA, IN ... | Duncan Jason | General Counsel | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
Jan 24 2019 | ALBO | ALBIREO PHARMA, IN ... | Mattsson Jan | Chief Operating Off ... | Option Exercise | A | 24.04 | 31,500 | 757,260 | 31,500 | |
Jan 24 2019 | ALBO | ALBIREO PHARMA, IN ... | Harford Simon N.R. | CFO and Treasurer | Option Exercise | A | 24.04 | 31,500 | 757,260 | 31,500 | |
Jan 24 2019 | ALBO | ALBIREO PHARMA, IN ... | Cooper Ronald Harold Wilfred | President and CEO | Option Exercise | A | 24.04 | 124,000 | 2,980,960 | 124,000 | |
Jan 24 2019 | ALBO | ALBIREO PHARMA, IN ... | Carter Martha J. | Chief Regulatory Of ... | Option Exercise | A | 24.04 | 31,500 | 757,260 | 31,500 | |
Nov 15 2018 | ALBO | ALBIREO PHARMA, IN ... | Cooper Ronald Harold Wilfred | President and CEO | Buy | P | 25.02 | 1,026 | 25,668 | 7,760 | 6.7 K to 7.8 K (+15.24 %) |
Oct 12 2018 | ALBO | ALBIREO PHARMA, IN ... | Harford Simon N.R. | CFO and Treasurer | Option Exercise | A | 27.98 | 37,500 | 1,049,250 | 37,500 | |
Oct 12 2018 | ALBO | ALBIREO PHARMA, IN ... | Harford Simon N.R. | CFO and Treasurer | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
Aug 16 2018 | ALBO | ALBIREO PHARMA, IN ... | Cooper Ronald Harold Wilfred | President and CEO | Buy | P | 32.50 | 200 | 6,500 | 6,734 | 6.5 K to 6.7 K (+3.06 %) |
Aug 16 2018 | ALBO | ALBIREO PHARMA, IN ... | Cooper Ronald Harold Wilfred | President and CEO | Buy | P | 31.63 | 588 | 18,598 | 6,534 | 5.9 K to 6.5 K (+9.89 %) |
Aug 08 2018 | ALBO | ALBIREO PHARMA, IN ... | Horn Patrick Taylor | Chief Medical Offic ... | Option Exercise | A | 31.54 | 37,500 | 1,182,750 | 37,500 | |
Jul 06 2018 | ALBO | ALBIREO PHARMA, IN ... | BROWN JULIA R | Director | Option Exercise | M | 9.00 | 3,333 | 29,997 | 0 | |
Jul 06 2018 | ALBO | ALBIREO PHARMA, IN ... | BROWN JULIA R | Director | Buy | M | 9.00 | 3,333 | 29,997 | 7,833 | 4.5 K to 7.8 K (+74.07 %) |
Jun 18 2018 | ALBO | ALBIREO PHARMA, IN ... | SCOON DAVEY | Director | Option Exercise | A | 32.53 | 5,500 | 178,915 | 5,500 | |
Jun 18 2018 | ALBO | ALBIREO PHARMA, IN ... | Okey Stephanie | Director | Option Exercise | A | 32.53 | 5,500 | 178,915 | 5,500 | |
Jun 18 2018 | ALBO | ALBIREO PHARMA, IN ... | Klibanski Anne | Director | Option Exercise | A | 32.53 | 5,500 | 178,915 | 5,500 | |
Jun 18 2018 | ALBO | ALBIREO PHARMA, IN ... | JEFFS ROGER | Director | Option Exercise | A | 32.53 | 5,500 | 178,915 | 5,500 | |
Jun 18 2018 | ALBO | ALBIREO PHARMA, IN ... | Gutch Michael | Director | Option Exercise | A | 32.53 | 5,500 | 178,915 | 5,500 | |
Jun 18 2018 | ALBO | ALBIREO PHARMA, IN ... | Chiswell David | Director | Option Exercise | A | 32.53 | 5,500 | 178,915 | 5,500 | |
Jun 14 2018 | ALBO | ALBIREO PHARMA, IN ... | Mattsson Jan | Chief Operating Off ... | Sell | S | 32.08 | 6,903 | 221,448 | 34,214 | 41.1 K to 34.2 K (-16.79 %) |
Jun 14 2018 | ALBO | ALBIREO PHARMA, IN ... | Mattsson Jan | Chief Operating Off ... | Sell | S | 33.23 | 2,421 | 80,450 | 41,117 | 43.5 K to 41.1 K (-5.56 %) |
Jun 14 2018 | ALBO | ALBIREO PHARMA, IN ... | Mattsson Jan | Chief Operating Off ... | Sell | S | 32.19 | 15,676 | 504,610 | 43,538 | 59.2 K to 43.5 K (-26.47 %) |
Jun 11 2018 | ALBO | ALBIREO PHARMA, IN ... | Soni Paresh | Chief Medical Offic ... | Option Exercise | A | 30.68 | 30,000 | 920,400 | 30,000 | |
Jun 11 2018 | ALBO | ALBIREO PHARMA, IN ... | Shea Thomas A. | CFO and Treasurer | Option Exercise | A | 30.68 | 30,000 | 920,400 | 30,000 | |
Jun 11 2018 | ALBO | ALBIREO PHARMA, IN ... | Mattsson Jan | Chief Operating Off ... | Option Exercise | A | 30.68 | 40,000 | 1,227,200 | 40,000 | |
Jun 11 2018 | ALBO | ALBIREO PHARMA, IN ... | JEFFS ROGER | Director | Option Exercise | A | 30.68 | 6,500 | 199,420 | 6,500 | |
Jun 11 2018 | ALBO | ALBIREO PHARMA, IN ... | Cooper Ronald Harold Wilfred | President and CEO | Option Exercise | A | 30.68 | 123,750 | 3,796,650 | 123,750 | |
Jun 11 2018 | ALBO | ALBIREO PHARMA, IN ... | Carter Martha J. | Chief Regulatory Of ... | Option Exercise | A | 30.68 | 30,000 | 920,400 | 30,000 | |
Jun 11 2018 | ALBO | ALBIREO PHARMA, IN ... | Okey Stephanie | Director | Option Exercise | A | 30.68 | 11,000 | 337,480 | 11,000 | |
Jun 11 2018 | ALBO | ALBIREO PHARMA, IN ... | Klibanski Anne | Director | Option Exercise | A | 30.68 | 11,000 | 337,480 | 11,000 | |
Jun 11 2018 | ALBO | ALBIREO PHARMA, IN ... | Duncan Jason | General Counsel | Option Exercise | A | 30.68 | 37,500 | 1,150,500 | 37,500 | |
Jun 11 2018 | ALBO | ALBIREO PHARMA, IN ... | BROWN JULIA R | Director | Option Exercise | M | 17.05 | 3,000 | 51,150 | 0 | |
Jun 11 2018 | ALBO | ALBIREO PHARMA, IN ... | BROWN JULIA R | Director | Option Exercise | M | 18.54 | 1,500 | 27,810 | 3,000 | |
Jun 11 2018 | ALBO | ALBIREO PHARMA, IN ... | BROWN JULIA R | Director | Buy | M | 17.05 | 3,000 | 51,150 | 4,500 | 1.5 K to 4.5 K (+200.00 %) |
Jun 11 2018 | ALBO | ALBIREO PHARMA, IN ... | BROWN JULIA R | Director | Buy | M | 18.54 | 1,500 | 27,810 | 1,500 | 0 to 1.5 K |
Feb 01 2018 | ALBO | ALBIREO PHARMA, IN ... | Phase4 Partners Ltd | Sell | S | 37.06 | 1,500 | 55,588 | 1,065,447 | 1.1 M to 1.1 M (-0.14 %) | |
Feb 01 2018 | ALBO | ALBIREO PHARMA, IN ... | Phase4 Partners Ltd | Sell | S | 34.40 | 98,500 | 3,388,459 | 1,066,947 | 1.2 M to 1.1 M (-8.45 %) | |
Jan 25 2018 | ALBO | ALBIREO PHARMA, IN ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 33.00 | 275,000 | 9,075,000 | 1,595,000 | 1.3 M to 1.6 M (+20.83 %) |
Dec 05 2017 | ALBO | ALBIREO PHARMA, IN ... | ASTRAZENECA PLC | 10% Owner | Sell | S | 21.40 | 500,000 | 10,700,000 | 508,141 | 1 M to 508.1 K (-49.60 %) |
Sep 29 2017 | ALBO | ALBIREO PHARMA, IN ... | JEFFS ROGER | Director | Option Exercise | A | 20.44 | 4,500 | 91,980 | 4,500 | |
Aug 23 2017 | ALBO | ALBIREO PHARMA, IN ... | Carter Martha J. | Chief Regulatory Of ... | Option Exercise | A | 24.48 | 13,000 | 318,240 | 13,000 | |
Aug 23 2017 | ALBO | ALBIREO PHARMA, IN ... | Zorn Peter A | Chief Corp. Officer ... | Option Exercise | A | 24.48 | 13,000 | 318,240 | 13,000 | |
Aug 23 2017 | ALBO | ALBIREO PHARMA, IN ... | Soni Paresh | Chief Medical Offic ... | Option Exercise | A | 24.48 | 13,000 | 318,240 | 13,000 | |
Aug 23 2017 | ALBO | ALBIREO PHARMA, IN ... | Shea Thomas A. | CFO and Treasurer | Option Exercise | A | 24.48 | 13,000 | 318,240 | 13,000 | |
Aug 23 2017 | ALBO | ALBIREO PHARMA, IN ... | Mattsson Jan | Chief Operating Off ... | Option Exercise | A | 24.48 | 13,000 | 318,240 | 13,000 | |
Aug 23 2017 | ALBO | ALBIREO PHARMA, IN ... | Cooper Ronald Harold Wilfred | President and CEO | Option Exercise | A | 24.48 | 60,000 | 1,468,800 | 60,000 | |
Jun 20 2017 | ALBO | ALBIREO PHARMA, IN ... | Pollard-Knight Denise | Director | Option Exercise | A | 17.05 | 3,000 | 51,150 | 3,000 | |
Jun 20 2017 | ALBO | ALBIREO PHARMA, IN ... | SCOON DAVEY | Director | Option Exercise | A | 17.05 | 3,000 | 51,150 | 3,000 | |
Jun 20 2017 | ALBO | ALBIREO PHARMA, IN ... | Gutch Michael | Director | Option Exercise | A | 17.05 | 3,000 | 51,150 | 3,000 | |
Jun 20 2017 | ALBO | ALBIREO PHARMA, IN ... | Chiswell David | Director | Option Exercise | A | 17.05 | 3,000 | 51,150 | 3,000 | |
Jun 20 2017 | ALBO | ALBIREO PHARMA, IN ... | BROWN JULIA R | Director | Option Exercise | A | 17.05 | 3,000 | 51,150 | 3,000 |